Margaret Olinger Amylyx Pharmaceuticals, Inc. (AMLX) insider trading activity

Margaret Olinger is Chief Commercial Officer of Amylyx Pharmaceuticals, Inc.. Currently has a direct ownership of 276,108 shares of AMLX, which is worth approximately $474,905. The most recent transaction as insider was on Dec 27, 2023, when has been sold 25,000 shares (Common Stock) at a price of $0.37 per share, resulting in proceeds of $9,250. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 276K

0% 3M change

19.47% 12M change

Total Value Held $474,905

Margaret Olinger Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 27 2023	BUY Exercise of conversion of derivative security	$9,250 $0.37 p/Share	25,000 Added 8.3%	276,108 Common Stock
Jul 12 2023	BUY Exercise of conversion of derivative security	$7,400 $0.37 p/Share	20,000 Added 7.38%	251,108 Common Stock
May 22 2023	SELL Bona fide gift	-	1,580 Reduced 0.68%	231,108 Common Stock
Mar 16 2023	BUY Grant, award, or other acquisition	-	18,333 Added 7.3%	232,688 Common Stock
Jan 06 2023	BUY Open market or private sale	$87,565 $36.44 p/Share	2,403 Added 1.11%	214,355 Common Stock
Jan 06 2022	BUY Grant, award, or other acquisition	-	28,333 Added 11.89%	209,916 Common Stock
Jan 06 2022	BUY Open market or private purchase	$129,998 $19.0 p/Share	6,842 Added 3.06%	216,758 Common Stock

Margaret Olinger

Chief Commercial Officer

Cambridge, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AMLX shares.

Notify only if

Value

Insider Trading

Get notified when an Amylyx Pharmaceuticals, Inc. insider buys or sells AMLX shares.

Notify only if

Operation

Value

Type

News

Receive news related to Amylyx Pharmaceuticals, Inc.

Track Activities on AMLX

Account